@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix go: . @prefix Protein: . @prefix sfam: . @prefix geneProductOf: . @prefix hasAgent: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix do: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasAgent: sub:_2; a go:0016301 . sub:_2 geneProductOf: sfam:MAPK%20p38%20Family; a Protein: . sub:_3 occursIn: do:3355, obo:CLO_0004276, species:9606; rdf:object sub:_1; rdf:predicate belv:directlyDecreases; rdf:subject schem:SB-203580; a rdf:Statement . sub:assertion rdfs:label "a(SCHEM:\"SB-203580\") =| kin(p(SFAM:\"MAPK p38 Family\"))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_5; pav:version "20131211" . sub:_4 prov:value "control and Sod2-overexpressing cells were treated with the specific inhibitors of ERK1/2 (PD98059) and p38 (SB203580) (Fig. 4B, inset). Northern blotting demonstrated that the ERK1/2 inhibitor blocked basal MMP-1 expression and dramatically decreased MMP-1 mRNA levels in the HT15 cell lines. The p38 inhibitor increased MMP-1 expression in both control and HT15 cell lines......the inductive properties of SB203580 could be blocked by PD98059."; prov:wasQuotedFrom pubmed:11297530 . sub:_5 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:11297530; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dct:created "2014-07-03T14:31:41.089+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }